New research is zeroing in on a biochemical basis for the placebo effect — possibly opening a Pandora’s box for Western medicine.
The Chain of Office of the Dutch city of Leiden is a broad and colorful ceremonial necklace that, draped around the shoulders of Mayor Henri Lenferink, lends a magisterial air to official proceedings in this ancient university town. But whatever gravitas it provided Lenferink as he welcomed a group of researchers to his city, he was quick to undercut it. “I am just a humble historian,” he told the 300 members of the Society for Interdisciplinary Placebo Studies who had gathered in Leiden’s ornate municipal concert hall, “so I don’t know anything about your topic.”
He was being a little disingenuous. He knew enough about the topic that these psychologists and neuroscientists and physicians and anthropologists and philosophers had come to his city to talk about — the placebo effect, the phenomenon whereby suffering people get better from treatments that have no discernible reason to work — to call it “fake medicine,” and to add that it probably works because “people like to be cheated.” He took a beat. “But in the end, I believe that honesty will prevail.”
Lenferink might not have been so glib had he attended the previous day’s meeting on the other side of town, at which two dozen of the leading lights of placebo science spent a preconference day agonizing over their reputation — as purveyors of sham medicine who prey on the desperate and, if they are lucky, fool people into feeling better — and strategizing about how to improve it. It’s an urgent subject for them, and only in part because, like all apostate professionals, they crave mainstream acceptance. More important, they are motivated by a conviction that the placebo is a powerful medical treatment that is ignored by doctors only at their patients’ expense.
And after a quarter-century of hard work, they have abundant evidence to prove it. Give people a sugar pill, they have shown, and those patients — especially if they have one of the chronic, stress-related conditions that register the strongest placebo effects and if the treatment is delivered by someone in whom they have confidence — will improve. Tell someone a normal milkshake is a diet beverage, and his gut will respond as if the drink were low fat. Take athletes to the top of the Alps, put them on exercise machines and hook them to an oxygen tank, and they will perform better than when they are breathing room air — even if room air is all that’s in the tank. Wake a patient from surgery and tell him you’ve done an arthroscopic repair, and his knee gets better even if all you did was knock him out and put a couple of incisions in his skin. Give a drug a fancy name, and it works better than if you don’t.
You don’t even have to deceive the patients. You can hand a patient with irritable bowel syndrome a sugar pill, identify it as such and tell her that sugar pills are known to be effective when used as placebos, and she will get better, especially if you take the time to deliver that message with warmth and close attention. Depression, back pain, chemotherapy-related malaise, migraine, post-traumatic stress disorder: The list of conditions that respond to placebos — as well as they do to drugs, with some patients — is long and growing.
But as ubiquitous as the phenomenon is, and as plentiful the studies that demonstrate it, the placebo effect has yet to become part of the doctor’s standard armamentarium — and not only because it has a reputation as “fake medicine” doled out by the unscrupulous to the credulous. It also has, so far, resisted a full understanding, its mechanisms shrouded in mystery. Without a clear knowledge of how it works, doctors can’t know when to deploy it, or how.
Not that the researchers are without explanations. But most of these have traditionally been psychological in nature, focusing on mechanisms like expectancy — the set of beliefs that a person brings into treatment — and the kind of conditioning that Ivan Pavlov first described more than a century ago. These theories, which posit that the mind acts upon the body to bring about physical responses, tend to strike doctors and researchers steeped in the scientific tradition as insufficiently scientific to lend credibility to the placebo effect. “What makes our research believable to doctors?” asks Ted Kaptchuk, head of Harvard Medical School’s Program in Placebo Studies and the Therapeutic Encounter. “It’s the molecules. They love that stuff.” As of now, there are no molecules for conditioning or expectancy — or, indeed, for Kaptchuk’s own pet theory, which holds that the placebo effect is a result of the complex conscious and nonconscious processes embedded in the practitioner-patient relationship — and without them, placebo researchers are hard-pressed to gain purchase in mainstream medicine.
Learn more: What if the Placebo Effect Isn’t a Trick?
The Latest on: Placebo effect
via Google News
The Latest on: Placebo effect
- Kiniksa's mavrilimumab shows positive effect in severely-ill COVID patientson May 11, 2020 at 7:36 am
Kiniksa Pharmaceuticals (KNSA +3.9%) announces positive results from an open-label, single-arm, single-center study in Italy evaluating mavrilimumab in 13 non-mechanically ventilated severely ill hosp ...
- New Research Explores Blueberries' Positive Effects In Men With Type 2 Diabeteson May 11, 2020 at 7:16 am
A new research study published in Current Developments in Nutrition found that the equivalent of one cup of fresh blueberries, given as 22 g of freeze-dried blueberries, may beneficially affect areas ...
- Transcriptomic signatures of treatment response to the combination of escitalopram and memantine or placebo in late-life depressionon May 7, 2020 at 10:26 am
Drugs that target glutamate neuronal transmission, such as memantine, offer a novel approach to the treatment of late-life depression, which is frequently comorbid with cognitive impairment. The ...
- FOURIER: Evolocumab Follow-up Shows No Cognitive Adverse Effectson May 5, 2020 at 11:20 am
The FOURIER pivotal outcomes trial showed no signal of mental harm related to treatment with the PCSK9 inhibitor or to the achievement of very low levels of low-density-lipoprotein cholesterol levels.
- Experimental drug shows 'positive effect' on COVID-19 recovery time in clinical trialon April 30, 2020 at 6:31 am
Researchers released some good news about a possible treatment for coronavirus Wednesday -- evidence that the experimental drug remdesivir might help patients recover more quickly from the infection.
- FDA will reportedly authorize use of remdesivir for Covid-19 after trial shows 'positive effect' on recovery timeon April 30, 2020 at 6:15 am
Patients with advanced Covid-19 who received the experimental drug remdesivir recovered faster than similar patients who received placebo, according to preliminary trial data, the National Institute o ...
- US says drug remdesivir shows ‘clear-cut’ effect in treating coronaviruson April 29, 2020 at 8:59 pm
COVID-19 patients who took the antiviral remdesivir recovered about 30 percent faster than those on a placebo, the results of a major clinical trial showed Wednesday, as the top US epidemiologist ...
- Coronavirus Treatment: Fauci Says Remdesivir Has 'Clear-Cut, Significant Positive Effect' On Patientson April 29, 2020 at 8:07 pm
Remdesivir, the candidate treatment for remdesivir, showed significant results in helping patients seriously ill from COVID-19 recover faster, and was given the nod by Dr. Anthony Fauci.
- Coronavirus drug remdesivir shows 'clear-cut positive effect' in US trialon April 29, 2020 at 5:30 pm
Experimental antiviral remdesivir holds promise as a treatment for COVID-19 -- but questions remain. Remdesivir, an experimental antiviral drug produced by biotech firm Gilead Sciences, has been one ...
via Bing News